Brown, Lisle/Cummings, Inc. Novo Nordisk A S Transaction History
Brown, Lisle/Cummings, Inc.
- $335 Billion
- Q4 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 48,858 shares of NVO stock, worth $4.13 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
48,858
Previous 50,195
2.66%
Holding current value
$4.13 Million
Previous $5.98 Billion
29.68%
% of portfolio
1.25%
Previous 1.82%
Shares
12 transactions
Others Institutions Holding NVO
# of Institutions
1,876Shares Held
318MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.68 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.21 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.21 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.12 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.03 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $191B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...